Form D · Biotechnology
Iambic Therapeutics, Inc.
San Diego, CA · CIK 0001997038
Offering snapshot reported Sep 9, 2026 · SEC filing
- Reported sold
- $66M Offering amount: $66.5M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 9, 2026 | Initial | $65,965,000 | No comparison | 16 | SEC filing |
| Apr 8, 2026 | Initial | $27,769,668 | No comparison | 7 | SEC filing |
| Nov 21, 2025 | Initial | $99,269,270 | No comparison | 22 | SEC filing |
| Jun 6, 2024 | Amendment | $38,383,040 | $11,508,049vs Apr 25, 2024 | 11 | SEC filing |
| May 7, 2024 | Amendment | $29,858,043 | $2,983,052vs Apr 25, 2024 | 8 | SEC filing |
| Apr 25, 2024 | Initial | $26,874,991 | No comparison | 7 | SEC filing |
| Oct 12, 2023 | Initial | $103,230,763 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-596810
Source: Form D, filed Sep 9, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jishnu Bhattacharjee | Director |
| Samit Hirawat | Director |
| Neil Josephson | Executive |
| Fred Manby | Director, Executive |
| Thomas Miller | Director, Executive |
| Pete Olson | Executive |
| Evan Rachlin | Director |
| William Rastetter | Director |
| Michael Secora | Executive |
| Shalini Sharp | Director |
| Mary Tagliaferri | Director |
| Tabbert Teng | Executive |
| R. Jacob Vogelstein | Director |
| Kurt Von Emster | Director |
| Chao Zhang | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5627 Oberlin Drive, Suite 120
San Diego, CA, 92121
Phone: (619) 330-5499
San Diego, CA, 92121
Phone: (619) 330-5499